SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is rallying as investors react to bipartisan efforts in Washington to pass the Clarity Act, sparking a wave of short liquidations and renewed institutional interest. The community is actively debating whether this momentum marks the end of the bear market or a potential bull trap, with many closely watching for a sustained breakout above major resistance levels.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple (XRP) is experiencing high volatility and increased whale activity following a high-profile industry summit at the White House, with the community actively debating whether this movement represents a sustainable trend or a temporary pump. Market participants are split between bullish sentiment tied to potential institutional adoption and regulatory clarity, and skeptical views warning of repeat patterns of short-term liquidations and price pullbacks.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is rallying after reporting record Q2 results that significantly beat market expectations on both revenue and earnings. The community is heavily focused on the stock's potential for a short squeeze and long-term valuation growth, with many investors debating the sustainability of the move while calling for a break above key psychological resistance levels.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is under significant pressure, facing a steep decline as investors weigh a recent analyst downgrade against concerns regarding slowing U.S. consumer spending and a high valuation that leaves little margin for error. While some in the community view the current sell-off as an attractive long-term entry point for a defensive staple, others are aggressively betting on further downside, pointing to weak technical trends and lingering fears about the broader economic climate.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant volatility following a major surge driven by positive Phase 3 cancer vaccine trial results. While the community is actively debating the potential long-term medical impact and valuation against institutional profit-taking, many traders are closely monitoring short interest and potential squeezes.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing a strong rally as investor sentiment shifts following a high-profile White House meeting on crypto policy and a broader market rebound fueled by U.S. Treasury bond buybacks. The community is actively debating the sustainability of this momentum, with bulls pointing to a potential short squeeze, while bears remain skeptical of the stock's long-term valuation and management's dilution strategy.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors weigh its aggressive pivot into AI and cloud infrastructure, highlighted by the rollout of its Qwen3.8-Max model and new monetization strategies. While the community remains divided between those viewing the stock as an undervalued AI powerhouse and others skeptical of the long-term impact of Chinese regulatory headwinds and heavy AI capital expenditures, the stock continues to see significant interest from swing traders looking for a potential re-rating.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending as investors weigh an earnings beat against concerns over future guidance and the sector's sensitivity to rising oil prices and geopolitical instability. The community is actively debating the stock's turnaround potential, with many traders focused on technical support levels and capitalizing on volatility while expressing frustration over the influence of hedge fund positioning.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market interest driven by its strategic $1.5 billion acquisition of Personalis, which strengthens its foothold in the lucrative minimal residual disease (MRD) cancer-monitoring market. Investors are closely watching the stock for a potential short squeeze, given high short interest, while community debate persists over the impact of insider selling and the long-term integration of these precision medicine assets.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending due to significant buying pressure and major short liquidations, bolstered by investor optimism surrounding the Clarity Act and broader crypto market momentum. The community is actively discussing a potential rotation into crypto as whales load up, with many focused on long-term growth and the impact of upcoming regulatory developments.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KOD One month from DAYBREAK and the setup keeps getting stronger. Zenkuda already has four successful Phase 3 trials behind it, including non-inferiority in wet AMD. DAYBREAK incorporates the lessons from earlier studies with loading doses, treat-to-dryness and individualized q4–q24w dosing.

Meanwhile, BLA preparation continues, ALTO is enrolling, PEAK is fully enrolled for Pivotal Analysis 1, and management just reconfirmed September for DAYBREAK.

Nothing is guaranteed in biotech, but I like the risk/reward here more than ever. Now let the data speak. 👀🔥

Stay Humble

StockTwits for iOS

Kodiak Sciences Inc

 One month from DAYBREAK and the setup keeps getting stronger. Zenkuda already has four successful Phase 3 trials behind it, including non-inferiority in wet AMD. DAYBREAK incorporates the lessons from earlier studies with loading doses, treat-to-dryness and individualized q4–q24w dosing.

Meanwhile, BLA preparation continues, ALTO is enrolling, PEAK is fully enrolled for Pivotal Analysis 1, and management just reconfirmed September for DAYBREAK.

Nothing is guaranteed in biotech, but I like the risk/reward here more than ever. Now let the data speak. 👀🔥

Mark Fuchs

@Stekli27 What’s your take on the ALTO study ? It kinda came from nowhere 🤔

 What’s your take on the ALTO study ? It kinda came from nowhere 🤔

@John_Smithh I actually see ALTO as a pretty bullish signal. It didn’t really come out of nowhere, KSI-501 was always intended to move beyond wet AMD if the program progressed well. What caught my attention is that Kodiak was confident enough to start a ~910-patient Phase 3 DME superiority study while DAYBREAK is still blinded. That’s a serious commitment of time and capital.

Obviously they don’t know the DAYBREAK results yet, but you don’t launch a trial of that size unless you have meaningful confidence in the drug and the platform. If KSI-501 shows a real efficacy advantage over aflibercept, ALTO could become a huge part of the story.

 I actually see ALTO as a pretty bullish signal. It didn’t really come out of nowhere, KSI-501 was always intended to move beyond wet AMD if the program progressed well. What caught my attention is that Kodiak was confident enough to start a ~910-patient Phase 3 DME superiority study while DAYBREAK is still blinded. That’s a serious commitment of time and capital.

Obviously they don’t know the DAYBREAK results yet, but you don’t launch a trial of that size unless you have meaningful confidence in the drug and the platform. If KSI-501 shows a real efficacy advantage over aflibercept, ALTO could become a huge part of the story.